Artiva Biotherapeutics (ARTV) Research & Development (2023 - 2026)
Artiva Biotherapeutics' Research & Development was $21.93 million in Q2 2026, up 22.8% from $17.86 million a year earlier and up 13.5% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Research & Development (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Artiva Biotherapeutics' Research & Development was $75.86 million through Jun 30, 2026, up 22.8% year-over-year; for FY2025, it was $69.54 million, up 38.2% from FY2024.
- In earlier years, Research & Development was $50.33 million in FY2024 (+0.2%) and $50.25 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q2 2023.
- Compared with a year earlier, Research & Development has increased for nine straight quarters, with growth averaging 26.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Research & Development ranged from 3.5% (Q3 2024) to 52.9% (Q1 2025).
- Per Business Quant data, ARTV's Research & Development in the three quarters before Q2 2026 was $19.31 million (Q1 2026), $16.99 million (Q4 2025) and $17.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.45 Bn | 1,141.04 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 637.59 Bn | 556.11 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.05 Bn | 477.16 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 377.18 Bn | 331.56 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.83 Bn | 197.23 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.51 Bn | 119.15 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Artiva Biotherapeutics | 250.87 Mn | -98.53 Mn | - | 21.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.93 Mn |
| Mar 31, 2026 | 19.31 Mn |
| Dec 31, 2025 | 16.99 Mn |
| Sep 30, 2025 | 17.63 Mn |
| Jun 30, 2025 | 17.86 Mn |
| Mar 31, 2025 | 17.05 Mn |
| Dec 31, 2024 | 13.32 Mn |
| Sep 30, 2024 | 13.52 Mn |
| Jun 30, 2024 | 12.33 Mn |
| Mar 31, 2024 | 11.16 Mn |
| Dec 31, 2023 | 11.15 Mn |
| Sep 30, 2023 | 13.07 Mn |
| Jun 30, 2023 | 11.26 Mn |
API Access
Artiva Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();